We found that TMEM176B expression on breast cancer cells was important for cell proliferation and migration, AKT/mTOR signaling, and the regulation of a number of genes involved in angiogenesis, KRAS signaling, EMT, and estrogen and interferon responses. Here, KRAS is linked to breast carcinoma.